AstraZeneca | Results Presentation Deck | 45 slides

AstraZeneca · 2023-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

45
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
front_matter
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
Includes a footer with definitions and guidance update.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
06
The slide uses two bar charts to compare revenue and growth rates across different segments.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
07
The slide uses an icon-grid layout to categorize the company's R&D focus areas.present_framework
Open slide detailBeat · NeedLoop · Logic Chain
08
transition
Open slide detailBeat · NeedLoop · Logic Chain
09
Includes CER (constant exchange rate) changes and percentage of total revenue metrics.analyze_data
Open slide detailLoop · Logic Chain
10
Includes footnotes regarding rounding, CER, and definitions of R&D, SG&A, and EPS.analyze_data
Open slide detailLoop · Logic Chain
11
Includes a waterfall chart for net debt and a comparison of updated vs previous financial guidance.analyze_data
Open slide detailLoop · Logic Chain
12
The slide uses a two-column layout to contrast the overarching strategy with specific investment priorities.present_framework
Open slide detailLoop · Logic Chain
13
The slide uses a two-column layout to contrast data integration (AZBrain) with specific application use cases.present_solution
Open slide detailLoop · Logic Chain
14
introduce_nominees
Open slide detailLoop · Logic Chain
15
The slide uses a navigation bar at the top to indicate the current section (Oncology).summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
16
The slide uses a dual-column layout to contrast a strategic roadmap for Tagrisso with a competitive performance chart for Calquence.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
17
Includes medical imaging and bar charts for clinical trial outcomes.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
18
Includes waterfall plots for two patient cohorts and a trial design schematic.analyze_data
Open slide detailBeat · SatisfactionLoop · Logic Chain
19
The slide uses a pipeline table and a waterfall chart to demonstrate clinical progress.summarize
Open slide detailBeat · SatisfactionLoop · Logic Chain
20
Includes a navigation bar at the top indicating this is part of a larger presentation.present_solution
Open slide detailBeat · SatisfactionLoop · Logic Chain
21
front_matter
22
Slide includes a navigation bar at the top indicating current section is BioPharmaceuticals.analyze_data
23
The slide uses a three-column layout to present distinct performance metrics for three key product areas.summarize
24
Uses a custom matrix-like layout to show drug combinations and monotherapies against disease prevalence segments.present_solution
25
Includes a bar chart for UACR reduction and a mechanism-of-action/pipeline diagram for tozorakimab.analyze_data
26
Includes a navigation bar at the top indicating the current section is 'BioPharmaceuticals'.size_opportunity
27
front_matter
28
Includes revenue breakdown for Ultomiris, Soliris, Strensiq, and others; regional breakdown; and C5 franchise indication mix.analyze_data
29
Includes clinical trial data visualization and market sizing for IgAN.summarize
30
summarize
Open slide detailBeat · Action
31
The slide uses a navigation bar at the top to indicate the current section is 'CEO Opening Remarks'.summarize
Open slide detailBeat · Action
32
Slide 32 of a presentation, likely AstraZeneca given the executives listed.other
Open slide detailBeat · Action
34
The slide uses color coding to distinguish between therapeutic areas: Oncology (dark purple), BioPharmaceuticals (light blue), and Rare Disease (magenta).summarize
35
The matrix uses color-coding and shading to distinguish between different drug classes and established standards of care.analyze_data
36
The slide uses a grid layout to categorize clinical trials by patient population and treatment line, with shading indicating established standard of care (SoC).analyze_data
37
The slide uses a matrix-like structure to map patient risk profiles against treatment lines, highlighting specific drug trials (e.g., SERENA, CAPItello, CAMBRIAanalyze_data
38
The chart tracks revenue performance across three categories over nine quarters.analyze_data
39
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
40
Contains two charts: a stacked bar chart for product sales and a grouped bar chart for collaboration revenue.analyze_data
41
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
42
CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.analyze_data
43
Data presented as stacked bar charts with corresponding data tables below each chart.analyze_data
44
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data
45
Data presented in stacked bar charts with corresponding data tables below each chart.analyze_data